Pier 88 Investment Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$27	–	118
2025 Q4	$27	Hold	10	–	–	﹤0.01%	117
2025 Q3	$22	Sell	10 -300	-97%	-$708	﹤0.01%	113
2025 Q2	$533	Sell	310 -126,630	-100%	-$315K	﹤0.01%	104
2025 Q1	$423K	Buy	126,940 +72,310	+132%	+$373K	0.08%	89
2024 Q4	$404K	Buy	54,630 +10,450	+24%	+$96.9K	0.08%	86
2024 Q3	$415K	Sell	44,180 -14,400	-25%	-$136K	0.09%	78
2024 Q2	$470K	Buy	58,580 +35,680	+156%	+$382K	0.11%	80
2024 Q1	$339K	Sell	22,900 -4,390	-16%	-$51.1K	0.08%	78
2023 Q4	$222K	Buy	+27,290	New	+$143K	0.06%	80
2021 Q4	–	Sell	-6,650	Closed	-$164K	–	117
2021 Q3	$164K	Buy	6,650 +5,030	+310%	+$119K	0.05%	106
2021 Q2	$42K	Sell	1,620 -15,706	-91%	-$408K	0.01%	110
2021 Q1	$549K	Sell	17,326 -3,165	-15%	-$131K	0.19%	89
2020 Q4	$951K	Sell	20,491 -19,990	-49%	-$794K	0.31%	71
2020 Q3	$1.33M	Buy	40,481 +29,256	+261%	+$897K	0.4%	51
2020 Q2	$308K	Buy	11,225 +2,035	+22%	+$66.9K	0.09%	96
2020 Q1	$275K	Buy	+9,190	New	+$244K	0.1%	86